Skin anti-aging strategies

Dermato-Endocrinology

Volumn 4, Issue 3, 2012, Pages

  Ganceviciene, Ruta ^a   Liakou, Aikaterini I ^b   Theodoridis, Athanasios ^b   Makrantonaki, Evgenia ^b   Zouboulis, Christos C ^b  

^a VILNIUS UNIVERSITY   (Lithuania)

^b DESSAU MEDICAL CENTER   (Germany)

Author keywords

Aging; Anti aging; Antioxidants; Botulinum toxin; Cell regulators; Fillers; Hormone replacement therapy; Laser; Peeling; Prevention

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BOTULINUM TOXIN; ISOFLAVONE; NICOTINAMIDE; POLYPHENOL; PRASTERONE; RETINAL; RETINOIC ACID; RETINOL; SUNSCREEN;

CUTANEOUS PARAMETERS; DERMATOLOGIST; DIET RESTRICTION; HORMONE SUBSTITUTION; HUMAN; INTENSE PULSED LIGHT THERAPY; LOW LEVEL LASER THERAPY; NUTRITION; PHYSICAL ACTIVITY; RADIOFREQUENCY ABLATION; REJUVENATION; REVIEW; SKIN CARE; SOYBEAN; THROMBOCYTE RICH PLASMA; ULTRAVIOLET IRRADIATION;

EID: 84871870488     PISSN: 19381972     EISSN: 19381980     Source Type: Journal    
DOI: 10.4161/derm.22804     Document Type: Review

References (209)

1. Cevenini E, Invidia L, Lescai F, Salvioli S, Tieri P, Castellani G, et al. Human models of aging and longevity. Expert Opin Biol Ther 2008; 8:1393-405; PMID:18694357; http://dx.doi.org/10.1517/14712598.8.9.1393.
2. Uitto J. Understanding premature skin aging. N Engl J Med 1997; 337:1463-5; PMID:9358147; http://dx.doi.org/10.1056/NEJM199711133372011.
3. Scaffidi P, Misteli T. Lamin A-dependent nuclear defects in human aging. Science 2006; 312:1059-63; PMID:16645051; http://dx.doi.org/10.1126/science. 1127168.
4. Fisher, G.J. The pathophysiology of photoaging of the skin. Cutis, 75, 5-9 (2005)58-69.
5. Schmuth M, Watson RE, Deplewski D, Dubrac S, Zouboulis CC, Griffiths CE. Nuclear hormone receptors in human skin. Horm Metab Res 2007; 39:96-105; PMID:17326005; http://dx.doi.org/10.1055/s-2007-961808.
6. Reichrath J, Lehmann B, Carlberg C, Varani J, Zouboulis CC. Vitamins as hormones. Horm Metab Res 2007; 39:71-84; PMID:17326003; http://dx.doi.org/10. 1055/s-2007-958715.
7. Verdier-Sévrain S, Bonté F, Gilchrest B. Biology of estrogens in skin: implications for skin aging. Exp Dermatol 2006; 15:83-94; PMID:16433679; http://dx.doi.org/10.1111/j.1600-0625.2005.00377.x.
8. Hall G, Phillips TJ. Estrogen and skin: the effects of estrogen, menopause, and hormone replacement therapy on the skin. J Am Acad Dermatol 2005; 53:555-68, quiz 569-72; PMID:16198774; http://dx.doi.org/10.1016/j.jaad.2004. 08.039.
9. Brincat MP, Baron YM, Galea R. Estrogens and the skin. Climacteric 2005; 8:110-23; PMID:16096167; http://dx.doi.org/10.1080/13697130500118100.
10. Draelos ZD. Topical and oral estrogens revisited for antiaging purposes. Fertil Steril 2005; 84:291-2, discussion 295; PMID:16084864; http://dx.doi.org/10.1016/j.fertnstert.2005.03.033.
11. Kanda N, Watanabe S. Regulatory roles of sex hormones in cutaneous biology and immunology. J Dermatol Sci 2005; 38:1-7; PMID:15795118; http://dx.doi.org/10.1016/j.jdermsci.2004.10.011.
12. Shin MH, Rhie GE, Park CH, Kim KH, Cho KH, Eun HC, et al. Modulation of collagen metabolism by the topical application of dehydroepiandrosterone to human skin. J Invest Dermatol 2005; 124:315-23; PMID:15675949; http://dx.doi.org/10.1111/j.0022-202X.2004.23588.x.
13. Kligman LH. Photoaging. Manifestations, prevention, and treatment. Clin Geriatr Med 1989; 5:235-51; PMID:2646001.
14. El-Domyati M, Attia S, Saleh F, Brown D, Birk DE, Gasparro F, et al. Intrinsic aging vs. photoaging: a comparative histopathological, immunohistochemical, and ultrastructural study of skin. Exp Dermatol 2002; 11:398-405; PMID:12366692; http://dx.doi.org/10.1034/j.1600-0625.2002.110502.x.
15. Moragas A, Castells C, Sans M. Mathematical morphologic analysis of aging-related epidermal changes. Anal Quant Cytol Histol 1993; 15:75-82; PMID:8318130.
16. Lock-Andersen J, Therkildsen P, de Fine Olivarius F, Gniadecka M, Dahlstrøm K, Poulsen T, et al. Epidermal thickness, skin pigmentation and constitutive photosensitivity. Photodermatol Photoimmunol Photomed 1997; 13:153-8; PMID:9453085; http://dx.doi.org/10.1111/j.1600-0781.1997.tb00220.x.
17. Makrantonaki E, Zouboulis CC. William J. Cunliffe Scientific Awards. Characteristics and pathomechanisms of endogenously aged skin. Dermatology 2007; 214:352-60; PMID:17460411; http://dx.doi.org/10.1159/000100890.
18. Makrantonaki E, Zouboulis CC. Molecular mechanisms of skin aging: state of the art. Ann N Y Acad Sci 2007; 1119:40-50; PMID:18056953; http://dx.doi.org/10.1196/annals.1404.027.
19. Escoffier C, de Rigal J, Rochefort A, Vasselet R, Lévêque JL, Agache PG. Age-related mechanical properties of human skin: an in vivo study. J Invest Dermatol 1989; 93:353-7; PMID:2768836; http://dx.doi.org/10. 1111/1523-1747.ep12280259.
20. Yaar M, Gilchrest BA. Aging of skin. In Fitzpatrick's Dermatology in General Medicine Vol 2, 5th edn. McGraw-Hill:New York, 1999; 1697-1706.
21. Baumann L. Skin ageing and its treatment. J Pathol 2007; 211:241-51; PMID:17200942; http://dx.doi.org/10.1002/path.2098.
22. Watson RE, Craven NM, Kang S, Jones CJ, Kielty CM, Griffiths CE. A short-term screening protocol, using fibrillin-1 as a reporter molecule, for photoaging repair agents. J Invest Dermatol 2001; 116:672-8; PMID:11348454; http://dx.doi.org/10.1046/j.1523-1747.2001.01322.x.
23. Contet-Audonneau JL, Jeanmaire C, Pauly G. A histological study of human wrinkle structures: comparison between sun-exposed areas of the face, with or without wrinkles, and sun-protected areas. Br J Dermatol 1999; 140:1038-47; PMID:10354068; http://dx.doi.org/10.1046/j.1365-2133.1999.02901.x.
24. Varani J, Spearman D, Perone P, Fligiel SE, Datta SC, Wang ZQ, et al. Inhibition of type I procollagen synthesis by damaged collagen in photoaged skin and by collagenase-degraded collagen in vitro. Am J Pathol 2001; 158:931-42; PMID:11238041; http://dx.doi.org/10.1016/S0002-9440(10)64040-0.
25. Brenneisen P, Oh J, Wlaschek M, Wenk J, Briviba K, Hommel C, et al. Ultraviolet B wavelength dependence for the regulation of two major matrix-metalloproteinases and their inhibitor TIMP-1 in human dermal fibroblasts. Photochem Photobiol 1996; 64:877-85; PMID:8931389; http://dx.doi.org/10.1111/j.1751-1097.1996.tb01851.x.
26. Fisher GJ, Datta SC, Talwar HS, Wang ZQ, Varani J, Kang S, et al. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature 1996; 379:335-9; PMID:8552187; http://dx.doi.org/10.1038/379335a0.
27. Fisher GJ, Wang ZQ, Datta SC, Varani J, Kang S, Voorhees JJ. Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med 1997; 337:1419-28; PMID:9358139; http://dx.doi.org/10.1056/ NEJM199711133372003.
28. Scharffetter-Kochanek K, Wlaschek M, Briviba K, Sies H. Singlet oxygen induces collagenase expression in human skin fibroblasts. FEBS Lett 1993; 331:304-6; PMID:8375513; http://dx.doi.org/10.1016/0014-5793(93)80357-Z.
29. Oikarinen A. The aging of skin: chronoaging versus photoaging. Photodermatol Photoimmunol Photomed 1990; 7:3-4; PMID:2371168.
30. Shuster S, Black MM, McVitie E. The influence of age and sex on skin thickness, skin collagen and density. Br J Dermatol 1975; 93:639-43; PMID:1220811; http://dx.doi.org/10.1111/j.1365-2133.1975.tb05113.x.
31. Bernstein EF, Underhill CB, Hahn PJ, Brown DB, Uitto J. Chronic sun exposure alters both the content and distribution of dermal glycosaminoglycans. Br J Dermatol 1996; 135:255-62; PMID:8881669; http://dx.doi.org/10.1111/j.1365- 2133.1996.tb01156.x.
32. Elsner P, Maibach HI. Cosmeceuticals and Active Cosmetics: Drugs versus Cosmetics (2nd edn). Marcel Dekker: New York, 2005.
33. Calasanti TM, Slevin KF, King N. Ageism and feminism: from 'et cetera' to center. NWSA J 2006; 18:13-30; http://dx.doi.org/10.2979/NWS.2006.18.1.13.
34. Bayer K. Cosmetic surgery and cosmetics: redefining the appearance of age. Generations 2005; 13-8. (Pubitemid 43060561)
35. Holstein MB, Minkler M. Self, society, and the "new gerontology". Gerontologist 2003; 43:787-96; PMID:14704376; http://dx.doi.org/10.1093/geront/43.6.787.
36. Mykytyn C. Anti-aging medicine: Predictions, moral obligations, and biomedical intervention. Anthropol Q 2006; 79:5-32; http://dx.doi.org/10.1353/ anq.2006.0010.
37. Wollina U, Payne CR. Aging well - the role of minimally invasive aesthetic dermatological procedures in women over 65. J Cosmet Dermatol 2010; 9:50-8; PMID:20367673; http://dx.doi.org/10.1111/j.1473-2165.2010.00475.x.
38. Vedamurthy M. Antiaging therapies. Indian J Dermatol Venereol Leprol 2006;72:183-6. (Pubitemid 43893184)
39. Dierickx CC, Anderson RR. Visible light treatment of photoaging. Dermatol Ther 2005; 18:191-208; PMID:16229721; http://dx.doi.org/10.1111/j.1529-8019. 2005.05019.x.
40. Tabata N, O'Goshi K, Zhen YX, Kligman AM, Tagami H. Biophysical assessment of persistent effects of moisturizers after their daily applications: evaluation of corneotherapy. Dermatology 2000; 200:308-13; PMID:10894961; http://dx.doi.org/10.1159/000018393.
41. Lübbe J. Evidence-based corneotherapy. Dermatology 2000; 200:285-9; PMID:10960243; http://dx.doi.org/10.1159/000018388.
42. Varani J, Warner RL, Gharaee-Kermani M, Phan SH, Kang S, Chung JH, et al. Vitamin A antagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and stimulates collagen accumulation in naturally aged human skin. J Invest Dermatol 2000; 114:480-6; PMID:10692106; http://dx.doi.org/10.1046/j.1523-1747.2000.00902.x.
43. Nusgens BV, Humbert P, Rougier A, Colige AC, Haftek M, Lambert CA, et al. Topically applied vitamin C enhances the mRNA level of collagens I and III, their processing enzymes and tissue inhibitor of matrix metalloproteinase 1 in the human dermis. J Invest Dermatol 2001; 116:853-9; PMID:11407971; http://dx.doi.org/10.1046/j.0022-202x.2001.01362.x.
44. Kockaert M, Neumann M. Systemic and topical drugs for aging skin. J Drugs Dermatol 2003; 2:435-41; PMID:12884471.
45. Margelin D, Medaisko C, Lombard D, Picard J, Fourtanier A. Hyaluronic acid and dermatan sulfate are selectively stimulated by retinoic acid in irradiated and nonirradiated hairless mouse skin. J Invest Dermatol 1996; 106:505-9; PMID:8648184; http://dx.doi.org/10.1111/1523-1747.ep12343819.
46. Trautinger F. Mechanisms of photodamage of the skin and its functional consequences for skin ageing. Clin Exp Dermatol 2001; 26:573-7; PMID:11696060; http://dx.doi.org/10.1046/j.1365-2230.2001.00893.x.
47. Berger MM. Can oxidative damage be treated nutritionally? Clin Nutr 2005; 24:172-83; PMID:15784476; http://dx.doi.org/10.1016/j.clnu.2004.10.003.
48. Marini A. Beauty from the inside. Does it really work?. Hautarzt 2011; 62:614-7; PMID:21732161; http://dx.doi.org/10.1007/s00105-011-2138-5.
49. Fusco D, Colloca G, Lo Monaco MR, Cesari M. Effects of antioxidant supplementation on the aging process. Clin Interv Aging 2007; 2:377-87; PMID:18044188.
50. Terada A, Yoshida M, Seko Y, Kobayashi T, Yoshida K, Nakada M, et al. Active oxygen species generation and cellular damage by additives of parenteral preparations: selenium and sulfhydryl compounds. Nutrition 1999; 15:651-5; PMID:10467607; http://dx.doi.org/10.1016/S0899-9007(99)00119-7.
51. Lin FH, Lin JY, Gupta RD, Tournas JA, Burch JA, Selim MA, et al. Ferulic acid stabilizes a solution of vitamins C and E and doubles its photoprotection of skin. J Invest Dermatol 2005; 125:826-32; PMID:16185284; http://dx.doi.org/ 10.1111/j.0022-202X.2005.23768.x.
52. Bissett DL, Miyamoto K, Sun P, Li J, Berge CA. Topical niacinamide reduces yellowing, wrinkling, red blotchiness, and hyperpigmented spots in aging facial skin. Int J Cosmet Sci 2004; 26:231-8; PMID:18492135; http://dx.doi.org/10.1111/j.1467-2494.2004.00228.x.
53. Haftek M, Mac-Mary S, Le Bitoux MA, Creidi P, Seité S, Rougier A, et al. Clinical, biometric and structural evaluation of the long-term effects of a topical treatment with ascorbic acid and madecassoside in photoaged human skin. Exp Dermatol 2008; 17:946-52; PMID:18503551; http://dx.doi.org/10.1111/j. 1600-0625.2008.00732.x.
54. Kerscher M, Buntrock H. Anti-aging creams. What really helps?. Hautarzt 2011; 62:607-13; PMID:21755353; http://dx.doi.org/10.1007/s00105-011-2137-6.
55. Murray JC, Burch JA, Streilein RD, Iannacchione MA, Hall RP, Pinnell SR. A topical antioxidant solution containing vitamins C and E stabilized by ferulic acid provides protection for human skin against damage caused by ultraviolet irradiation. J Am Acad Dermatol 2008; 59:418-25; PMID:18603326; http://dx.doi.org/10.1016/j.jaad.2008.05.004.
56. Draelos ZD. The latest cosmeceutical approaches for anti-aging. J Cosmet Dermatol 2007; 6:2-6; PMID:17348987; http://dx.doi.org/10.1111/j.1473-2165.2007. 00313.x.
57. Zhai H, Behnam S, Villarama CD, Arens-Corell M, Choi MJ, Maibach HI. Evaluation of the antioxidant capacity and preventive effects of a topical emulsion and its vehicle control on the skin response to UV exposure. Skin Pharmacol Physiol 2005; 18:288-93; PMID:16145283; http://dx.doi.org/10.1159/ 000088014.
58. Elmets CA, Singh D, Tubesing K, Matsui M, Katiyar S, Mukhtar H. Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. J Am Acad Dermatol 2001; 44:425-32; PMID:11209110; http://dx.doi.org/10.1067/mjd.2001. 112919.
59. Kafi R, Kwak HS, Schumacher WE, Cho S, Hanft VN, Hamilton TA, et al. Improvement of naturally aged skin with vitamin A (retinol). Arch Dermatol 2007; 143:606-12; PMID:17515510; http://dx.doi.org/10.1001/archderm.143.5.606.
60. Varani J, Warner RL, Gharaee-Kermani M, Phan SH, Kang S, Chung JH, et al. Vitamin A antagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and stimulates collagen accumulation in naturally aged human skin. J Invest Dermatol 2000; 114:480-6; PMID:10692106; http://dx.doi.org/10.1046/j.1523-1747.2000.00902.x.
61. Bhawan J. Short- and long-term histologic effects of topical tretinoin on photodamaged skin. Int J Dermatol 1998; 37:286-92; PMID:9585903; http://dx.doi.org/10.1046/j.1365-4362.1998.00433.x.
62. Lupo MP, Cole AL. Cosmeceutical peptides. Dermatol Ther 2007; 20:343-9; PMID:18045359; http://dx.doi.org/10.1111/j.1529-8019.2007.00148.x.
63. Nelson BR, Majmudar G, Griffiths CE, Gillard MO, Dixon AE, Tavakkol A, et al. Clinical improvement following dermabrasion of photoaged skin correlates with synthesis of collagen I. Arch Dermatol 1994; 130:1136-42; PMID:8085868; http://dx.doi.org/10.1001/archderm.1994.01690090060008.
64. Ostler EL, Wallis CV, Aboalchamat B, Faragher RG. Telomerase and the cellular lifespan: implications of the aging process. J Pediatr Endocrinol Metab 2000; 13(Suppl 6):1467-76; PMID:11202223.
65. Monheit GD, Chastain MA. Chemical peels. Facial Plast Surg Clin North Am 2001; 9:239-55, viii; PMID:11457690.
66. Fischer TC, Perosino E, Poli F, Viera MS, Dreno B; Cosmetic Dermatology European Expert Group. Chemical peels in aesthetic dermatology: an update 2009. J Eur Acad Dermatol Venereol 2010; 24:281-92; PMID:19744174; http://dx.doi.org/10.1111/j.1468-3083.2009.03409.x.
67. Brown AM, Kaplan LM, Brown ME. Phenol-induced histological skin changes: hazards, technique, and uses. Br J Plast Surg 1960; 13:158-69; PMID:13804881; http://dx.doi.org/10.1016/S0007-1226(60)80032-X.
68. Fartasch M, Teal J, Menon GK. Mode of action of glycolic acid on human stratum corneum: ultrastructural and functional evaluation of the epidermal barrier. Arch Dermatol Res 1997; 289:404-9; PMID:9248619; http://dx.doi.org/10. 1007/s004030050212.
69. Deprez P. Textbook of Chemical Peels. Superficial, Medium, and Deep Peels in Cosmetic Practice. Informa UK, London, 2007.
70. Baker TJ, Gordon HL. The ablation of rhytides by chemical means; a preliminary report. J Fla Med Assoc 1961; 48:541.
71. Behin F, Feuerstein SS, Marovitz WF. Comparative histological study of mini pig skin after chemical peel in an animal model after chemical peel and dermabrasion. Arch Otolaryngol 1977; 103:271; PMID:856133; http://dx.doi.org/10. 1001/archotol.1977.00780220065006.
72. Vagotis FL, Brundage SR. Histologic study of dermabrasion and chemical peel in an animal model after pretreatment with Retin-A. Aesthetic Plast Surg 1995; 19:243-6; PMID:7668170; http://dx.doi.org/10.1007/BF00451097.
73. Han SH, Kim HJ, Kim SY, Kim YC, Choi GS, Shin JH. Effects of chemical peeling in photoaged hairless mice. Int J Dermatol 2011; 50:1075-82; PMID:22126868; http://dx.doi.org/10.1111/j.1365-4632.2010.04712.x.
74. Butler PE, Gonzalez S, Randolph MA, Kim J, Kollias N, Yaremchuk MJ. Quantitative and qualitative effects of chemical peeling on photo-aged skin: an experimental study. Plast Reconstr Surg 2001; 107:222-8; PMID:11176627; http://dx.doi.org/10.1097/00006534-200101000-00036.
75. Nelson BR, Fader DJ, Gillard M, Majmudar G, Johnson TM. Pilot histologic and ultrastructural study of the effects of medium-depth chemical facial peels on dermal collagen in patients with actinically damaged skin. J Am Acad Dermatol 1995; 32:472-8; PMID:7868719; http://dx.doi.org/10.1016/0190-9622(95)90072-1.
76. El-Domyati MB, Attia SK, Saleh FY, Ahmad HM, Uitto JJ. Trichloroacetic acid peeling versus dermabrasion: a histometric, immunohistochemical, and ultrastructural comparison. Dermatol Surg 2004; 30:179-88; PMID:14756647; http://dx.doi.org/10.1111/j.1524-4725.2004.30061.x.
77. Sadick NS. Update on non-ablative light therapy for rejuvenation: a review. Lasers Surg Med 2003; 32:120-8; PMID:12561045; http://dx.doi.org/10. 1002/lsm.10127.
78. Hardaway CA, Ross EV. Nonablative laser skin remodeling. Dermatol Clin 2002; 20:97-111, ix; PMID:11859598; http://dx.doi.org/10.1016/S0733-8635(03) 00049-4.
79. Bjerring P, Christiansen K, Troilius A, Dierickx C. Facial photo rejuvenation using two different intense pulsed light (IPL) wavelength bands. Lasers Surg Med 2004; 34:120-6; PMID:15004823; http://dx.doi.org/10.1002/lsm. 20000.
80. Goldberg DJ. Full-face nonablative dermal remodeling with a 1320 nm Nd:YAG laser. Dermatol Surg 2000; 26:915-8; PMID:11050492; http://dx.doi.org/10. 1046/j.1524-4725.2000.026010915.x.
81. Goldberg DJ, Rogachefsky AS, Silapunt S. Nonablative laser treatment of facial rhytides: a comparison of 1450-nm diode laser treatment with dynamic cooling as opposed to treatment with dynamic cooling alone. Lasers Surg Med 2002; 30:79-81; PMID:11870784; http://dx.doi.org/10.1002/lsm.10011.
82. Fournier N, Dahan S, Barneon G, Rouvrais C, Diridollou S, Lagarde JM, et al. Nonablative remodeling: a 14-month clinical ultrasound imaging and profilometric evaluation of a 1540 nm Er:Glass laser. Dermatol Surg 2002; 28:926-31; PMID:12410677; http://dx.doi.org/10.1046/j.1524-4725.2002.02078.x.
83. Bjerring P, Clement M, Heickendorff L, Egevist H, Kiernan M. Selective non-ablative wrinkle reduction by laser. J Cutan Laser Ther 2000; 2:9-15; PMID:11446096.
84. Zelickson BD, Kilmer SL, Bernstein E, Chotzen VA, Dock J, Mehregan D, et al. Pulsed dye laser therapy for sun damaged skin. Lasers Surg Med 1999; 25:229-36; PMID:10495300; http://dx.doi.org/10.1002/(SICI)1096-9101(1999)25: 3〈229::AID-LSM7〉3.0.CO;2-D.
85. Goldberg D, Tan M, Dale Sarradet M, Gordon M. Nonablative dermal remodeling with a 585-nm, 350-microsec, flashlamp pulsed dye laser: clinical and ultrastructural analysis. Dermatol Surg 2003; 29:161- 3, discussion 163-4; PMID:12562346; http://dx.doi.org/10.1046/j.1524-4725.2003.29040.x.
86. Prieto VG, Sadick NS, Lloreta J, Nicholson J, Shea CR. Effects of intense pulsed light on sun-damaged human skin, routine, and ultrastructural analysis. Lasers Surg Med 2002; 30:82-5; PMID:11870785; http://dx.doi.org/10.1002/lsm. 10042.
87. Tanghetti E, Sherr E. Treatment of telangiectasia using the multi-pass technique with the extended pulse width, pulsed dye laser (Cynosure V-Star). J Cosmet Laser Ther 2003; 5:71-5; PMID:12850799; http://dx.doi.org/10.1080/ 14769170310001249.
88. Alam M, Dover JS, Arndt KA. Treatment of facial telangiectasia with variable-pulse high-fluence pulsed-dye laser: comparison of efficacy with fluences immediately above and below the purpura threshold. Dermatol Surg 2003; 29:681-4, discussion 685; PMID:12828690; http://dx.doi.org/10.1046/j.1524-4725. 2003.29181.x.
89. Negishi K, Wakamatsu S, Kushikata N, Tezuka Y, Kotani Y, Shiba K. Full-face photorejuvenation of photodamaged skin by intense pulsed light with integrated contact cooling: initial experiences in Asian patients. Lasers Surg Med 2002; 30:298-305; PMID:11948600; http://dx.doi.org/10.1002/lsm.10036.
90. Negishi K, Tezuka Y, Kushikata N, Wakamatsu S. Photorejuvenation for Asian skin by intense pulsed light. Dermatol Surg 2001; 27:627-31, discussion 632; PMID:11442612; http://dx.doi.org/10.1046/j.1524-4725.2001.01002.x.
91. Omi T, Kawana S, Sato S, Honda M. Ultrastructural changes elicited by a non-ablative wrinkle reduction laser. Lasers Surg Med 2003; 32:46-9; PMID:12516070; http://dx.doi.org/10.1002/lsm.10119.
92. Zelickson B, Kist D. Effect of pulsed dye laser and intense pulse light source in dermal extracellular matrix remodeling. Lasers Surg Med 2000; S12:68.
93. Hsu TS, Zelickson B, Dover JS, Kilmer S, Burns J, Hruza G, et al. Multicenter study of the safety and efficacy of a 585 nm pulsed-dye laser for the nonablative treatment of facial rhytides. Dermatol Surg 2005; 31:1-9; PMID:15720087.
94. Moody BR, McCarthy JE, Hruza GJ. Collagen remodeling after 585-nm pulsed dye laser irradiation: an ultrasonographic analysis. Dermatol Surg 2003; 29:997-9, discussion 999-1000; PMID:12974694; http://dx.doi.org/10.1046/j.1524- 4725.2003.29290.x.
95. Bjerring P, Clement M, Heickendorff L, Lybecker H, Kiernan M. Dermal collagen production following irradiation by dye laser and broadband light source. J Cosmet Laser Ther 2002; 4:39-43; PMID:12470517; http://dx.doi.org/10. 1080/147641702320602555.
96. Dahiya R, Lam SM, Williams EF 3rd. A systematic histologic analysis of nonablative laser therapy in a porcine model using the pulsed dye laser. Arch Facial Plast Surg 2003; 5:218-23; PMID:12756114; http://dx.doi.org/10.1001/ archfaci.5.3.218.
97. Goldberg DJ, Cutler KB. Nonablative treatment of rhytids with intense pulsed light. Lasers Surg Med 2000; 26:196-200; PMID:10685092; http://dx.doi.org/10.1002/(SICI)1096-9101(2000)26:2〈196::AIDLSM10〉3.0. CO;2-9.
98. Goldberg DJ. New collagen formation after dermal remodeling with an intense pulsed light source. J Cutan Laser Ther 2000; 2:59-61; PMID:11360318.
99. Hernández-Pérez E, Ibiett EV. Gross and microscopic findings in patients submitted to nonablative full-face resurfacing using intense pulsed light: a preliminary study. Dermatol Surg 2002; 28:651-5; PMID:12174053; http://dx.doi.org/10.1046/j.1524-4725.2002.02010.x.
100. Alster TS, Garg S. Treatment of facial rhytides with a high-energy pulsed carbon dioxide laser. Plast Reconstr Surg 1996; 98:791-4; PMID:8823015; http://dx.doi.org/10.1097/00006534-199610000-00005.
101. Lowe NJ, Lask G, Griffin ME, Maxwell A, Lowe P, Quilada F. Skin resurfacing with the Ultrapulse carbon dioxide laser. Observations on 100 patients. Dermatol Surg 1995; 21:1025-9; PMID:7496669; http://dx.doi.org/10. 1016/1076-0512(96)82352-1.
102. Fitzpatrick RE, Goldman MP, Satur NM, Tope WD. Pulsed carbon dioxide laser resurfacing of photoaged facial skin. Arch Dermatol 1996; 132:395-402; PMID:8629842; http://dx.doi.org/10.1001/archderm.1996.03890280047007.
103. Teikemeier G, Goldberg DJ. Skin resurfacing with the erbium:YAG laser. Dermatol Surg 1997; 23:685-7; PMID:9256915; http://dx.doi.org/10.1016/S1076- 0512(97)00179-9.
104. Biesman BS. Fractional ablative skin resurfacing: complications. Lasers Surg Med 2009; 41:177-8; PMID:19291748; http://dx.doi.org/10.1002/lsm.20764.
105. Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med 2004; 34:426-38; PMID:15216537; http://dx.doi.org/10.1002/lsm.20048.
106. Farkas JP, Richardson JA, Hoopman J, Brown SA, Kenkel JM. Micro-island damage with a nonablative 1540-nm Er:Glass fractional laser device in human skin. J Cosmet Dermatol 2009; 8:119-26; PMID:19527336; http://dx.doi.org/10. 1111/j.1473-2165.2009.00441.x.
107. Laubach HJ, Tannous Z, Anderson RR, Manstein D. Skin responses to fractional photothermolysis. Lasers Surg Med 2006; 38:142-9; PMID:16392146; http://dx.doi.org/10.1002/lsm.20254.
108. Helbig D, Paasch U. Molecular changes during skin aging and wound healing after fractional ablative photothermolysis. Skin Res Technol 2011; 17:119-28; PMID:21226879; http://dx.doi.org/10.1111/j.1600-0846.2010.00477.x.
109. Hantash BM, Bedi VP, Kapadia B, Rahman Z, Jiang K, Tanner H, et al. In vivo histological evaluation of a novel ablative fractional resurfacing device. Lasers Surg Med 2007; 39:96-107; PMID:17311274; http://dx.doi.org/10.1002/lsm. 20468.
110. Arany PR, Nayak RS, Hallikerimath S, Limaye AM, Kale AD, Kondaiah P. Activation of latent TGF-beta1 by low-power laser in vitro correlates with increased TGF-beta1 levels in laser-enhanced oral wound healing. Wound Repair Regen 2007; 15:866-74; PMID:18028135; http://dx.doi.org/10.1111/j.1524-475X. 2007.00306.x.
111. Souil E, Capon A, Mordon S, Dinh-Xuan AT, Polla BS, Bachelet M. Treatment with 815-nm diode laser induces long-lasting expression of 72-kDa heat shock protein in normal rat skin. Br J Dermatol 2001; 144:260-6; PMID:11251556; http://dx.doi.org/10.1046/j.1365-2133.2001.04010.x.
112. Wilmink GJ, Opalenik SR, Beckham JT, Abraham AA, Nanney LB, Mahadevan-Jansen A, et al. Molecular imaging-assisted optimization of hsp70 expression during laser-induced thermal preconditioning for wound repair enhancement. J Invest Dermatol 2009; 129:205-16; PMID:18580963; http://dx.doi.org/10.1038/jid.2008.175.
113. Ravanti L, Kähäri VM. Matrix metalloproteinases in wound repair (review). Int J Mol Med 2000; 6:391-407; PMID:10998429.
114. Orringer JS, Kang S, Johnson TM, Karimipour DJ, Hamilton T, Hammerberg C, et al. Connective tissue remodeling induced by carbon dioxide laser resurfacing of photodamaged human skin. Arch Dermatol 2004; 140:1326-32; PMID:15545540; http://dx.doi.org/10.1001/archderm.140.11.1326.
115. Raulin C, Greve B, Grema H. IPL technology: a review. Lasers Surg Med 2003; 32:78-87; PMID:12561039; http://dx.doi.org/10.1002/lsm.10145.
116. Iorizzo M, De Padova MP, Tosti A. Biorejuvenation: theory and practice. Clin Dermatol 2008; 26:177-81; PMID:18472058; http://dx.doi.org/10.1016/j. clindermatol.2007.09.011.
117. Rotunda AM, Kolodney MS. Mesotherapy and phosphatidylcholine injections: historical clarification and review. Dermatol Surg 2006; 32:465-80; PMID:16681654; http://dx.doi.org/10.1111/j.1524-4725.2006.32100.x.
118. Caruso MK, Roberts AT, Bissoon L, Self KS, Guillot TS, Greenway FL. An evaluation of mesotherapy solutions for inducing lipolysis and treating cellulite. J Plast Reconstr Aesthet Surg 2008; 61:1321-4; PMID:17954040; http://dx.doi.org/10.1016/j.bjps.2007.03.039.
119. Matarasso A, Pfeifer TM; Plastic Surgery Educational Foundation DATA Committee. Mesotherapy for body contouring. Plast Reconstr Surg 2005; 115:1420-4; PMID:15809611; http://dx.doi.org/10.1097/01.PRS.0000162227.94032.ED.
120. Rotunda AM, Avram MM, Avram AS. Cellulite: Is there a role for injectables? J Cosmet Laser Ther 2005; 7:147-54; PMID:16414902; http://dx.doi.org/10.1080/14764170500430234.
121. Lacarrubba F, Tedeschi A, Nardone B, Micali G. Mesotherapy for skin rejuvenation: assessment of the subepidermal low-echogenic band by ultrasound evaluation with cross-sectional B-mode scanning. Dermatol Ther 2008; 21(Suppl 3):S1-5; PMID:19076625; http://dx.doi.org/10.1111/j.1529-8019.2008.00234.x.
122. Jager C, Brenner C, Habicht J, Wallic R. Bioactive reagents used in mesotherapy for skin rejuvenation in vivo induce diverse physiological processes in human skin fibroblasts in vitro - a pilot study. Exp Dermatol 2011; 21:70-80; PMID:22082171.
123. Amin SP, Phelps RG, Goldberg DJ. Mesotherapy for facial skin rejuvenation: a clinical, histologic, and electron microscopic evaluation. Dermatol Surg 2006; 32:1467-72; PMID:17199654; http://dx.doi.org/10.1111/j.1524- 4725.2006.32353.x.
124. Atiyeh BS, Ibrahim AE, Dibo SA. Aesthetic Plast Surg 2008: 32: 842-849.
125. Brown S A. Aesthet Surg J 2006; 26:95-8; PMID:19338891.
126. Eppley BL, Dadvand B. Injectable soft-tissue fillers: clinical overview. Plast Reconstr Surg 2006; 118:98e-106e; PMID:16980841; http://dx.doi.org/10. 1097/01.prs.0000232436.91409.30.
127. Haneke E. Skin rejuvenation without a scalpel. I. Fillers. J Cosmet Dermatol 2006; 5:157-67; PMID:17173591; http://dx.doi.org/10.1111/j.1473-2165. 2006.00243.x.
128. Homicz MR, Watson D. Review of injectable materials for soft tissue augmentation. Facial Plast Surg 2004; 20:21-9; PMID:15034810; http://dx.doi.org/10.1055/s-2004-822955.
129. Kanchwala SK, Holloway L, Bucky LP. Reliable soft tissue augmentation: a clinical comparison of injectable soft-tissue fillers for facial-volume augmentation. Ann Plast Surg 2005; 55:30-5, discussion 35; PMID:15985788; http://dx.doi.org/10.1097/01.sap.0000168292.69753.73.
130. Klein AW. Techniques for soft tissue augmentation: an 'a to z'. Am J Clin Dermatol 2006; 7:107-20; PMID:16605291; http://dx.doi.org/10.2165/00128071- 200607020-00004.
131. Laurent TC, Fraser JR. Hyaluronan. FASEB J 1992; 6:2397-404; PMID:1563592.
132. Tzellos TG, Klagas I, Vahtsevanos K, Triaridis S, Printza A, Kyrgidis A, et al. Extrinsic ageing in the human skin is associated with alterations in the expression of hyaluronic acid and its metabolizing enzymes. Exp Dermatol 2009; 18:1028-35; PMID:19601984; http://dx.doi.org/10.1111/j.1600-0625.2009.00889.x.
133. Alberts B, Johnson A, Lewis J, et al., eds. 2002. The molecular biology of the cell. Cell junctions, cell adhesion, and the extracellular matrix. 1065. New York: Garland Science.
134. Sherman L, Sleeman J, Herrlich P, Ponta H. Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr Opin Cell Biol 1994; 6:726-33; PMID:7530464; http://dx.doi.org/10.1016/0955-0674(94) 90100-7.
135. Turley EA. Hyaluronan and cell locomotion. Cancer Metastasis Rev 1992; 11:21-30; PMID:1380898; http://dx.doi.org/10.1007/BF00047600.
136. Papakonstantinou E, Karakiulakis G, Eickelberg O, Perruchoud AP, Block L-H, Roth M. A 340 kDa hyaluronic acid secreted by human vascular smooth muscle cells regulates their proliferation and migration. Glycobiology 1998; 8:821-30; PMID:9639543; http://dx.doi.org/10.1093/glycob/8.8.821.
137. Tammi MI, Day AJ, Turley EA. Hyaluronan and homeostasis: a balancing act. J Biol Chem 2002; 277:4581-4; PMID:11717316; http://dx.doi.org/10.1074/jbc. R100037200.
138. Fligiel SE, Varani J, Datta SC, Kang S, Fisher GJ, Voorhees JJ. Collagen degradation in aged/photo-damaged skin in vivo and after exposure to matrix metalloproteinase-1 in vitro. J Invest Dermatol 2003; 120:842-8; PMID:12713591; http://dx.doi.org/10.1046/j.1523-1747.2003.12148.x.
139. Kuroda K, Shinkai H. Gene expression of types I and III collagen, decorin, matrix metalloproteinases and tissue inhibitors of metalloproteinases in skin fibroblasts from patients with systemic sclerosis. Arch Dermatol Res 1997; 289:567-72; PMID:9373715; http://dx.doi.org/10.1007/s004030050241.
140. Uitto J, Bernstein EF. Molecular mechanisms of cutaneous aging: connective tissue alterations in the dermis. J Investig Dermatol Symp Proc 1998; 3:41-4; PMID:9732056.
141. Yoneda M, Shimizu S, Nishi Y, Yamagata M, Suzuki S, Kimata K. Hyaluronic acid-dependent change in the extracellular matrix of mouse dermal fibroblasts that is conducive to cell proliferation. J Cell Sci 1988; 90:275-86; PMID:3073165.
142. Gao F, Liu Y, He Y, Yang C, Wang Y, Shi X, et al. Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis. Matrix Biol 2010; 29:107-16; PMID:19913615; http://dx.doi.org/10.1016/j.matbio. 2009.11.002.
143. Jiang D, Liang J, Noble PW. Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol 2007; 23:435-61; PMID:17506690; http://dx.doi.org/10.1146/ annurev.cellbio.23.090506.123337.
144. Fink RM, Lengfelder E. Hyaluronic acid degradation by ascorbic acid and influence of iron. Free Radic Res Commun 1987; 3:85-92; PMID:3508446; http://dx.doi.org/10.3109/10715768709069773.
145. Carruthers A, Carruthers J. Non-animal-based hyaluronic acid fillers: scientific and technical considerations. Plast Reconstr Surg 2007; 120(Suppl):33S-40S; PMID:18090341; http://dx.doi.org/10.1097/01.prs.0000248808. 75700.5f.
146. Balazs EA, Bland PA, Denlinger JL, Goldman AI, Larsen NE, Leshchiner EA, et al. Matrix engineering. Blood Coagul Fibrinolysis 1991; 2:173-8; PMID:1772987; http://dx.doi.org/10.1097/00001721-199102000-00026.
147. Andre P. New trends in face rejuvenation by hyaluronic acid injections. J Cosmet Dermatol 2008; 7:251-8; PMID:19146600; http://dx.doi.org/10.1111/j.1473- 2165.2008.00402.x.
148. Eppley BL, Dadvand B. Injectable soft-tissue fillers: clinical overview. Plast Reconstr Surg 2006; 118:98e-106e; PMID:16980841; http://dx.doi.org/10. 1097/01.prs.0000232436.91409.30.
149. Gold MH. Use of hyaluronic acid fillers for the treatment of the aging face. Clin Interv Aging 2007; 2:369-76; PMID:18044187.
150. Robinson JK, Hanke CW, Sengelmann RD, Siegel DM. Surgery of the skin. Philadelphia: Elsevier Mosby, 2005.
151. Alam M, Gladstone H, Kramer EM, Murphy JP Jr., Nouri K, Neuhaus IM, et
152. Lizzul PF, Narurkar VA. The role of calcium hydroxylapatite (Radiesse) in nonsurgical aesthetic rejuvenation. J Drugs Dermatol 2010; 9:446-50; PMID:20480786.
153. Goldberg DJ. Breakthroughs in US dermal fillers for facial soft-tissue augmentation. J Cosmet Laser Ther 2009; 11:240-7; PMID:19951196; http://dx.doi.org/10.3109/14764170903341731.
154. Ghersetich I, Lotti T, Campanile G, Grappone C, Dini G. Hyaluronic acid in cutaneous intrinsic aging. Int J Dermatol 1994; 33:119-22; PMID:8157393; http://dx.doi.org/10.1111/j.1365-4362.1994.tb01540.x.
155. Graivier MH, Bass LS, Busso M, Jasin ME, Narins RS, Tzikas TL. Calcium hydroxylapatite (Radiesse) for correction of the mid- and lower face: consensus recommendations. Plast Reconstr Surg 2007; 120(Suppl):55S-66S; PMID:18090343; http://dx.doi.org/10.1097/01.prs.0000285109.34527.b9.
156. Tzikas TL. A 52-month summary of results using calcium hydroxylapatite for facial soft tissue augmentation. Dermatol Surg 2008; 34(Suppl 1):S9-15; PMID:18547188; http://dx.doi.org/10.1111/j.1524-4725.2008.34237.x.
157. Burgess CM, Lowe NJ. NewFill for skin augmentation: a new filler or failure? Dermatol Surg 2006; 32:1530-2, author reply 1532; PMID:17199668; http://dx.doi.org/10.1111/j.1524-4725.2006.32369.x.
158. Mest D. Experience with injectable poly-L-lactic acid in clinicalpractice. Cosmetic Dermatol 2005; 18:5-8. (Pubitemid 40262166)
159. Burgess CM, Quiroga RM. Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy. J Am Acad Dermatol 2005; 52:233-9; PMID:15692467; http://dx.doi.org/10.1016/j.jaad. 2004.08.056.
160. Sturm LP, Cooter RD, Mutimer KL, Graham JC, Maddern GJ. A systematic review of dermal fillers for age-related lines and wrinkles. ANZ J Surg 2011; 81:9-17; PMID:21299793; http://dx.doi.org/10.1111/j.1445-2197.2010.05351.x.
161. Zimmermann R, Jakubietz R, Jakubietz M, Strasser E, Schlegel A, Wiltfang J, et al. Different preparation methods to obtain platelet components as a source of growth factors for local application. Transfusion 2001; 41:1217-24; PMID:11606819; http://dx.doi.org/10.1046/j.1537-2995.2001.41101217.x.
162. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 2004; 62:489-96; PMID:15085519; http://dx.doi.org/10.1016/j. joms.2003.12.003.
163. Freymiller EG. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 2004; 62:1046, author reply 1047-8; PMID:15278876; http://dx.doi.org/10.1016/j.joms.2004.05.205.
164. Wrotniak M, Bielecki T, Gaździk TS. Current opinion about using the platelet-rich gel in orthopaedics and trauma surgery. Ortop Traumatol Rehabil 2007; 9:227-38; PMID:17721419.
165. Kim DH, Je YJ, Kim CD, Lee YH, Seo YJ, Lee JH, et al. Can Platelet-rich Plasma Be Used for Skin Rejuvenation? Evaluation of Effects of Platelet-rich Plasma on Human Dermal Fibroblast. Ann Dermatol 2011; 23:424-31.
166. Krasna M, Domanovic D, Tomsic A, Svajger U, Jeras M. Platelet gel stimulates proliferation of human dermal fibroblasts in vitro. Acta Dermatovenerol Alp Panonica Adriat 2007; 16:105-10. (Pubitemid 47621660)
167. Lucarelli E, Beccheroni A, Donati D, Sangiorgi L, Cenacchi A, Del Vento AM, et al. Platelet-derived growth factors enhance proliferation of human stromal stem cells. Biomaterials 2003; 24:3095-100; PMID:12895582; http://dx.doi.org/10.1016/S0142-9612(03)00114-5.
168. Kanno T, Takahashi T, Tsujisawa T, Ariyoshi W, Nishihara T. Platelet-rich plasma enhances human osteoblast-like cell proliferation and differentiation. J Oral Maxillofac Surg 2005; 63:362-9; PMID:15742288; http://dx.doi.org/10.1016/ j.joms.2004.07.016.
169. Dessy LA, Mazzocchi M, Rubino C, Mazzarello V, Spissu N, Scuderi N. An objective assessment of botulinum toxin A effect on superficial skin texture. Ann Plast Surg 2007; 58:469-73; PMID:17452827; http://dx.doi.org/10.1097/01.sap. 0000244968.16977.1f.
170. Cheng CM. Cosmetic use of botulinum toxin type A in the elderly. Clin Interv Aging 2007; 2:81-3; PMID:18044078; http://dx.doi.org/10.2147/ciia.2007.2. 1.81.
171. Rzany B, Dill-Müller D, Grablowitz D, Heckmann M, Caird D; German-Austrian Retrospective Study Group. Repeated botulinum toxin A injections for the treatment of lines in the upper face: a retrospective study of 4,103 treatments in 945 patients. Dermatol Surg 2007; 33(1 Spec No.):S18-25; PMID:17241409; http://dx.doi.org/10.1111/j.1524-4725.2006.32327.x.
172. Böni R, Kreyden OP, Burg G. Revival of the use of botulinum toxin: application in dermatology. Dermatology 2000; 200:287-91; PMID:10894957; http://dx.doi.org/10.1159/000018389.
173. Coffield JA, Considine RB, Simpson LL. The site and mechanism of action of botulinum neurotoxin; in Jankovic J, Hallett M (eds): Therapy with Botulinum Toxin. New York, Dekker, 1994, pp 3-14.
174. Coleman WP, Hanke CW, Alt TH. Cosmetic Surgery of the Skin, 2nd edn. St Louis, Missouri: Mosby Year Book Inc., 1997: 231-235.
175. Garcia A, Fulton JE Jr. Cosmetic denervation of the muscles of facial expression with botulinum toxin. A dose-response study. Dermatol Surg 1996; 22:39-43; PMID:8556256; http://dx.doi.org/10.1016/1076-0512(95)00464-5.
176. Carruthers A, Kiene K, Carruthers J. Botulinum A exotoxin use in clinical dermatology. J Am Acad Dermatol 1996; 34:788-97; PMID:8632076; http://dx.doi.org/10.1016/S0190-9622(96)90016-X.
177. Guyuron B, Huddleston SW. Aesthetic indications for botulinum toxin injection. Plast Reconstr Surg 1994; 93:913-8; PMID:8134483; http://dx.doi.org/10.1097/00006534-199404001-00003.
178. Brooks GF, Butel JS, Ornston LN. Jawetz, Melnick and Adelbergs Medical Microbiology, 20th edn. Connecticut: Appleton and Lange, 1995: 174±176.
179. Aoki RK. Immunologic and other properties of therapeutic botulinum toxin serotypes. In: BrinMF, Hallett M, Jankovic J, eds. Scientific and Therapeutic Aspects of Botulinum Toxin. Philadelphia, PA: Lippincott Williams & Wilkins; 2002.
180. Becker-Wegerich P, Rauch L, Ruzicka T. Botulinum toxin A in the therapy of mimic facial lines. Clin Exp Dermatol 2001; 26:619-30; PMID:11696067; http://dx.doi.org/10.1046/j.1365-2230.2001.00901.x.
181. Ganong WF. Review of Medical Physiology, 16th edn. East Norwalk, Connecticut: Appleton and Lange, 1993: 99±102.
182. de Paiva A, Meunier FA, Molgó J, Aoki KR, Dolly JO. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci U S A 1999; 96:3200-5; PMID:10077661; http://dx.doi.org/10. 1073/pnas.96.6.3200.
183. Product Information Package Insert. (71390US12J). Irvine, CA: Allergan, Inc.; 2002.
184. Hatheway CG. Immunology of Botulinum Toxin. New York: Marcel-Dekker; 1993.
185. Huang W, Foster JA, Rogachefsky AS. Pharmacology of botulinum toxin. J Am Acad Dermatol 2000; 43:249-59; PMID:10906647; http://dx.doi.org/10.1067/mjd. 2000.105567.
186. Rzany B, Ascher B, Monheit GD. Treatment of glabellar lines with botulinum toxin type A (Speywood Unit): a clinical overview. J Eur Acad Dermatol Venereol 2010; 24(Suppl 1):1-14; PMID:19930409; http://dx.doi.org/10.1111/j. 1468-3083.2009.03475.x.
187. Botox (Package Insert). Allergan, Inc.
188. Carruthers J, Fagien S, Matarasso SL. the Botox Consensus Group. Botulinum toxin and facial aesthetics. Plast Reconstr Surg 2004; 114:1S-22S; PMID:15507786; http://dx.doi.org/10.1097/01.PRS.0000144795.76040.D3.
189. Shetty MK; IADVL Dermatosurgery Task Force. Guidelines on the use of botulinum toxin type A. Indian J Dermatol Venereol Leprol 2008; 74(Suppl):S13-22; PMID:18688099.
190. Sommer B, Sattler G. Botulinumtoxin in der aÈs-thetischen Medizin. Berlin; Blackwell Vissenschafts-Verlag, 2001.
191. Carruthers J, Carruthers A. Cosmetic use of botulinum A exotoxin. In: Advances in Dermatology (Dzubow L, ed.) 1996: 280-303.
192. Lange DJ, Rubin M, Greene PE, Kang UJ, Moskowitz CB, Brin MF, et al. Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes. Muscle Nerve 1991; 14:672-5; PMID:1922173; http://dx.doi.org/10.1002/mus.880140711.
193. Goschel H, et al. Botulinum toxin therapy, neutralizing and non-neutralizing antibodies. Exp Neurol 1997; 147:96; PMID:9294406; http://dx.doi.org/10.1006/exnr.1997.6580.
194. Blitzer A, Binder WJ, Boyd JB, Carruthers A. Management of Facial Lines and Wrinkles. Philadelphia, PA: Lippincott Williams & Wilkins; 2000.
195. Matarasso A, Deva AK; American Society of Plastic Surgeons DATA Committee. Botulinum toxin. Plast Reconstr Surg 2002; 109:1191-7; PMID:11884859; http://dx.doi.org/10.1097/00006534-200203000-00066.
196. Fagien S. Botox for the treatment of dynamic and hyperkinetic facial lines and furrows: adjunctive use in facial aesthetic surgery. Plast Reconstr Surg 1999; 103:701-13; PMID:9950563; http://dx.doi.org/10.1097/00006534- 199902000-00055.
197. Hertoghe T. The "multiple hormone deficiency" theory of aging: is human senescence caused mainly by multiple hormone deficiencies? Ann N Y Acad Sci 2005; 1057:448-65; PMID:16399912; http://dx.doi.org/10.1196/annals.1322. 035.
198. Cranney A, Papaioannou A, Zytaruk N, Hanley D, Adachi J, Goltzman D, et al.; Clinical Guidelines Committee of Osteoporosis Canada. Parathyroid hormone for the treatment of osteoporosis: a systematic review. CMAJ 2006; 175:52-9; PMID:16818910; http://dx.doi.org/10.1503/cmaj.050929.
199. Vitetta L, Anton B. Lifestyle and nutrition, caloric restriction, mitochondrial health and hormones: scientific interventions for anti-aging. Clin Interv Aging 2007; 2:537-43; PMID:18225453.
200. Heutling D, Lehnert H. [Hormone therapy and antiaging: is there an indication?]. Internist (Berl) 2008; 49:570-80, 572-6, 578-9; PMID:18389196; http://dx.doi.org/10.1007/s00108-008-2110-3.
201. Morales AJ, Nolan JJ, Nelson JC, Yen SS. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994; 78:1360-7; PMID:7515387; http://dx.doi.org/10.1210/jc.78.6.1360.
202. Baulieu EE, Thomas G, Legrain S, Lahlou N, Roger M, Debuire B, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci U S A 2000; 97:4279-84; PMID:10760294; http://dx.doi.org/10.1073/pnas.97.8.4279.
203. Jankowski CM, Gozansky WS, Schwartz RS, Dahl DJ, Kittelson JM, Scott SM, et al. Effects of dehydro-epiandrosterone replacement therapy on bone mineral density in older adults: a randomized, controlled trial. J Clin Endocrinol Metab 2006; 91:2986-93; PMID:16735495; http://dx.doi.org/10.1210/jc.2005-2484.
204. Nair KS, Rizza RA, O'Brien P, Dhatariya K, Short KR, Nehra A, et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 2006; 355:1647-59; PMID:17050889; http://dx.doi.org/10.1056/NEJMoa054629.
205. Wetterberg L, Bergiannaki JD, Paparrigopoulos T, von Knorring L, Eberhard G, Bratlid T, et al. Normative melatonin excretion: a multinational study. Psychoneuroendocrinology 1999; 24:209-26; PMID:10101729; http://dx.doi.org/10. 1016/S0306-4530(98)00076-6.
206. Roth GS, Lesnikov V, Lesnikov M, Ingram DK, Lane MA. Dietary caloric restriction prevents the agerelated decline in plasma melatonin levels of rhesus monkeys. J Clin Endocrinol Metab 2001; 86:3292-5; PMID:11443203; http://dx.doi.org/10.1210/jc.86.7.3292.
207. Ferrari E, Cravello L, Falvo F, Barili L, Solerte SB, Fioravanti M, et al. Neuroendocrine features in extreme longevity. Exp Gerontol 2008; 43:88-94; PMID:17764865; http://dx.doi.org/10.1016/j.exger.2007.06.010.
208. Blask DE, Dauchy RT, Sauer LA. Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal. Endocrine 2005; 27:179-88; PMID:16217131; http://dx.doi.org/10.1385/ENDO:27:2:179.
209. Heutling D, Lehnert H. Hormone therapy and menopause. Dtsch Med Wochenschr 2005; 130:829-34; PMID:15789305; http://dx.doi.org/10.1055/s-2005- 865097.